Chief Medical Officer and VP, Clinical Affairs @ Metabolex
David Karpf's Education
UCSF School of Medicine
Fellowship in Osteoporosis & metabolic Bone Disease (Osteoporosis, bone biology, metabolic bone disease, PTH receptor, PTH actions)
1985 - 1986
Cedars-Sinai Medical Center/UCLA Combined Program
Fellowship in Endocrinology, Diabetes & Metabolsim (Endocrinology, Diabetes and Metabolism Residency Program)
1983 - 1985
Cedars-Sinai Medical Center/UCLA
Residency in Internal Medicine (Internal Medicine Residency Program)
1980 - 1983
University of California, San Diego - School of Medicine
MD (Medicine)
1976 - 1980
University of California, Berkeley
B.A. (Pre-med; Psychology; Tumor cell biology)
1972 - 1976
University of California, Los Angeles
Advanced standing (UCLA High School Honors Program)
1971 - 1972
David Karpf's Skills
Clinical Research
Oncology
Endocrinology
FDA
Cell
Cancer
Data Analysis
Commercialization
Microsoft Office
Clinical Development
David Karpf's Summary
David Karpf, based in Hayward, CA, US, is currently a Chief Medical Officer at Lumos Pharma, bringing experience from previous roles at Mezomax Inc., Stanford University School of Medicine, Reneo Pharmaceuticals and Spruce Biosciences. David Karpf holds a 1985 - 1986 Fellowship in Osteoporosis & metabolic Bone Disease in Osteoporosis, bone biology, metabolic bone disease, PTH receptor, PTH actions @ UCSF School of Medicine. With a robust skill set that includes Clinical Research, Oncology, Endocrinology, FDA, Cell and more, David Karpf contributes valuable insights to the industry. David Karpf has 4 emails and 1 mobile phone number on RocketReach.